No abstract available
MeSH terms
-
Cost-Benefit Analysis
-
Humans
-
Immunity, Active
-
Pneumococcal Infections / immunology
-
Pneumococcal Infections / prevention & control*
-
Pneumococcal Vaccines* / immunology
-
Risk Factors
-
Vaccines, Conjugate / immunology
Substances
-
Pneumococcal Vaccines
-
Vaccines, Conjugate